Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1

NCT01661621 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
395
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Buddhist Tzu Chi General Hospital